Medical Oncology

Richard Francis Riedel, MD

Associate Professor of Medicine
Member of the Duke Cancer Institute
Campus mail Dept Of Medicine, 25179 Morris Bldg, Durham, NC 27710
Phone (919) 681-8031
Email address richard.riedel@duke.edu

Novel therapies for soft tissue and bone sarcomas

In Their Words

Education and Training

  • Fellow in Hematology-Oncology, Medicine, Duke University, 2005 - 2007
  • Fellow in Hematology-Oncology, Medicine, Duke University, 2003 - 2004
  • Resident in Medicine, Medicine, Duke University, 2000 - 2003
  • M.D., Thomas Jefferson University, 2000

Grants

Publications

Abdulla, DSY, Scheffler, M, Brandes, V, Ruge, M, Kunze, S, Merkelbach-Bruse, S, Nogova, L, Michels, S, Fischer, R, Riedel, R, Büttner, R, Persigehl, T, Grau, S, Galldiks, N, Drzezga, A, Kobe, C, and Wolf, J. "Monitoring Treatment Response to Erlotinib in EGFR-mutated Non-small-cell Lung Cancer Brain Metastases Using Serial O-(2-[18F]fluoroethyl)-L-tyrosine PET." Clinical Lung Cancer 20, no. 2 (March 2019): e148-e151.

PMID
30528316
Full Text

Schwartz, AJ, Riedel, RF, LeBlanc, TW, Desai, D, Jenkins, C, Mahoney, E, Humphreys, J, and Hendrix, CC. "The experiences of older caregivers of cancer patients following hospital discharge." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 27, no. 2 (February 2019): 609-616.

PMID
30027328
Full Text

Scheffler, M, Ihle, MA, Hein, R, Merkelbach-Bruse, S, Scheel, AH, Siemanowski, J, Brägelmann, J, Kron, A, Abedpour, N, Ueckeroth, F, Schüller, M, Koleczko, S, Michels, S, Fassunke, J, Pasternack, H, Heydt, C, Serke, M, Fischer, R, Schulte, W, Gerigk, U, Nogova, L, Ko, YD, Abdulla, DSY, Riedel, R, Kambartel, KO, Lorenz, J, Sauerland, I, Randerath, W, Kaminsky, B, Hagmeyer, L, Grohé, C, Eisert, A, Frank, R, Gogl, L, Schaepers, C, Holzem, A, Hellmich, M, Thomas, RK, Peifer, M, Sos, ML, Büttner, R, and Wolf, J. "K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways." Journal of Thoracic Oncology (January 1, 2019).

Full Text

Riedel, RF. "Anti-angiogenic therapy for malignant solitary fibrous tumour: validation through collaboration." The Lancet. Oncology 20, no. 1 (January 2019): 14-15.

PMID
30578024
Full Text

Gounder, MM, Mahoney, MR, Van Tine, BA, Ravi, V, Attia, S, Deshpande, HA, Gupta, AA, Milhem, MM, Conry, RM, Movva, S, Pishvaian, MJ, Riedel, RF, Sabagh, T, Tap, WD, Horvat, N, Basch, E, Schwartz, LH, Maki, RG, Agaram, NP, Lefkowitz, RA, Mazaheri, Y, Yamashita, R, Wright, JJ, Dueck, AC, and Schwartz, GK. "Sorafenib for Advanced and Refractory Desmoid Tumors." The New England Journal of Medicine 379, no. 25 (December 2018): 2417-2428.

PMID
30575484
Full Text

Ray, EM, Riedel, RF, LeBlanc, TW, Rushing, CN, and Galanos, AN. "Assessing the Impact of a Novel Integrated Palliative Care and Medical Oncology Inpatient Service on Health Care Utilization before Hospice Enrollment." Journal of Palliative Medicine (November 3, 2018).

PMID
30394821
Full Text

Riedel, RF, Jones, RL, Italiano, A, Bohac, C, Thompson, JC, Mueller, K, Khan, Z, Pollack, SM, and Van Tine, BA. "Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review." Cancers 10, no. 11 (November 2018). (Review)

PMID
30388821
Full Text

Vlahovic, G, Meadows, KL, Hatch, AJ, Jia, J, Nixon, AB, Uronis, HE, Morse, MA, Selim, MA, Crawford, J, Riedel, RF, Zafar, SY, Howard, LA, O'Neill, M, Meadows, JJ, Haley, ST, Arrowood, CC, Rushing, C, Pang, H, and Hurwitz, HI. "A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer." The Oncologist 23, no. 7 (July 2018): 782-790.

PMID
29572245
Full Text

Gounder, MM, Somaiah, N, Attia, S, Chawla, SP, Villalobos, VM, Chmielowski, B, Burgess, MA, Schwartz, GK, Riedel, RF, von Mehren, M, Wagner, AJ, Choy, E, Verma, S, Mudenda, B, Sadanowicz, M, Shah, JJ, Li, L, Shacham, S, Kauffman, MG, and Abdul Razak, AR. "Phase 2 results of selinexor in advanced de-differentiated (DDLS) liposarcoma (SEAL) study: A phase 2/3, randomized, double blind, placebo controlled cross-over study.": American Society of Clinical Oncology (ASCO), May 20, 2018.

Full Text

Wisdom, AJ, Mowery, YM, Riedel, RF, and Kirsch, DG. "Rationale and emerging strategies for immune checkpoint blockade in soft tissue sarcoma." Cancer (May 3, 2018). (Review)

PMID
29723407
Full Text

Pages